Gilead Sciences, incorporated on June 22, 1987, is a research-based biopharmaceutical company engaged in the development and marketing of pharmaceutical products. Gilead's primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases such as hepatitis B and C, and cardiovascular/metabolic and respiratory conditions.